CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Palliative cancer care - dyspnoea - Management
What are the symptomatic treatment options for dyspnoea in palliative care?
- In all cases, consider simple measures to relieve dyspnoea.
- Determine what management interventions are appropriate for the underlying cause of dyspnoea and stage of illness, involving the person and their carers and family.
- Based on this, consider symptomatic measures if appropriate (e.g. an opioid, a benzodiazepine, a corticosteroid, a bronchodilator, or oxygen).
Basis for recommendation
- This recommendation is pragmatic advice based on expert opinion from palliative care specialists.
© NHS Institute for Innovation and Improvement